Cleveland BioLabs
CBLI
$3.17
Share price
-7.31%
Change (1 day)
N/A
Change (1 year)
Categories
Revenue for Cleveland BioLabs (CBLI)
Revenue in 2020 (TTM): $0.63 M
According to Cleveland BioLabs 's latest financial reports the company's current revenue (TTM) is $0.63 M. In 2019 the company made a revenue of $1.11 M a decrease over the years 2018 revenue that were of $1.13 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Cleveland BioLabs from 2004 to 2020
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2020 (TTM) | $0.63 M | -43.25% |
| 2019 | $1.11 M | -2.18% |
| 2018 | $1.13 M | -41.58% |
| 2017 | $1.94 M | -44.62% |
| 2016 | $3.51 M | 29.92% |
| 2015 | $2.7 M | -26.84% |
| 2014 | $3.7 M | -56.39% |
| 2013 | $8.48 M | 137.71% |
| 2012 | $3.57 M | -59.38% |
| 2011 | $8.79 M | -42.67% |
| 2010 | $15.33 M | 6.87% |
| 2009 | $14.34 M | 204.87% |
| 2008 | $4.7 M | 133.12% |
| 2007 | $2.01 M | 18.17% |
| 2006 | $1.7 M | 50% |
| 2005 | $1.13 M | 78.97% |
| 2004 | $0.63 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Novartis NVS | $51.01 B | 8,073,437.37% | 🇨🇭 Switzerland |
 Eli Lilly LLY | $34.12 B | 5,400,633.09% | 🇺🇸 USA |
 Amgen AMGN | $28.19 B | 4,461,458.43% | 🇺🇸 USA |
 Sanofi SNY | $50.35 B | 7,970,233.23% | 🇫🇷 France |
 Bristol-Myers Squibb BMY | $45.00 B | 7,122,883.28% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $37.84 B | 5,990,170.67% | 🇬🇧 UK |
 Soligenix SNGX | $0.83 M | 32.84% | 🇺🇸 USA |
 OPKO Health
OPK | $0.86 B | 136,562.96% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | $0.22 M | -64.23% | 🇺🇸 USA |